Cristin H Cowles

IP, Technology And Data; Patents - Chemical, Pharma, Biotech

Cristin Cowles has over 20 years of experience practicing in patent-related matters, including patent prosecution, patent lifecycle management, due diligence evaluations, patentability analyses, freedom-to-operate determinations, inventorship investigations, and validity opinions. Cristin has represented a wide range of clients, including large pharmaceutical companies, biotechnology companies, academic institutions, and early-stage life science companies.

Cristin’s practice and technical experience focuses mainly on molecular biology and biochemistry, including biologics, such as antibodies and antibody drug conjugates (ADCs), biologic manufacturing processes, protein formulations, CAR-T and TCR immunotherapy technologies, biomarkers, and platform technologies. Cristin has experience developing and managing international patent portfolios directed to blockbuster therapeutic antibodies, and is experienced in life cycle management for biologic drug products. She has extensive foreign patent prosecution experience, and has assisted with oral proceedings and oppositions before the European and Indian patent offices.

Cristin received her Ph.D. from Princeton University in Molecular Biology, where she identified a novel maternally expressed T-box gene, eomesodermin, in zebrafish. Her research has been presented at several scientific meetings, and has been published in leading journals in the field of developmental biology.